Referências

1. Ferlay J., Soerjomataram I., Ervik M., Et al., GLOBOCAN 2012 v1.0, (2013)
2. Siegel R.L., Miller K.D., Jemal A., Cancer statistics, 2018, CA Cancer J Clin, 68, pp. 7-30, (2018)
3. Goldstraw P., Chansky K., Crowley J., Et al., The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer, J Thorac Oncol, 11, 1, pp. 39-51, (2016)
4. Torre L.A., Siegel R.L., Jemal A., Lung cancer statistics, Adv Exp Med Biol, 893, pp. 1-19, (2016)
5. De Groot P.M., Wu C.C., Carter B.W., Munden R.F., The epidemiology of lung cancer, Transl Lung Cancer Res, 7, 3, pp. 220-233, (2018)
6. Janerich D.T., Thompson W.D., Varela L.R., Et al., Lung cancer and exposure to tobacco smoke in the household, N Engl J Med, 323, 10, pp. 632-636, (1990)
7. Pershagen G., Air pollution and cancer, IARC Sci Publ, 104, pp. 240-251, (1990)
8. Driscoll T., Nelson D.I., Steenland K., Et al., The global burden of disease due to occupational carcinogens, Am J Ind Med, 48, 6, pp. 419-431, (2005)
9. Dela Cruz C.S., Tanoue L.T., Matthay R.A., Lung cancer: Epidemiology, etiology, and prevention, Clin Chest Med, 32, 4, pp. 605-644, (2011)
10. Kesner V.G., Oh S.J., Dimachkie M.M., Barohn R.J., Lambert-Eaton Myasthenic syndrome, Neurol Clin, 36, 2, pp. 379-394, (2018)
11. Aberle D.R., Adams A.M., Et al., Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, 365, (2011)
12. De Koning H., Van Der Aalst C., Ten Haaf K., Oudkerk M., PL02, J Thorac Oncol, 13, 10, (2018)
13. Bueno J., Landeras L., Chung J.H., Updated Fleischner society guidelines for managing incidental pulmonary nodules: Common questions and challenging scenarios, Radiographics, 38, 5, pp. 1337-1350, (2018)
14. Schenk D.A., Bryan C.L., Bower J.H., Myers D.L., Transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma, Chest, 92, 1, pp. 83-85, (1987)
15. Sampsonas F., Kakoullis L., Lykouras D., Karkoulias K., Spiropoulos K., EBUS: Faster, cheaper and most effective in lung cancer staging, Int J Clin Pract, 72, 2, (2018)
16. Rivera M.P., Mehta A.C., Wahidi M.M., Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 143, 5, pp. (*)([A-z]), (2013)
17. Wiener R.S., Schwartz L.M., Woloshin S., Et al., Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: An analysis of discharge records, Ann Intern Med, 155, pp. 137-144, (2011)
18. Dennie C.J., Matzinger F.R., Marriner J.R., Et al., Transthoracic needle biopsy of the lung: Results of early discharge in 506 outpatients, Radiology, 219, pp. 247-251, (2001)
19. Travis W.D., Brambilla E.W., Burke A.P., Et al., WHO classification of tumours of the lung, pleura, thymus, and heart, (2015)
20. Janssen-Heijnen M.L., Coebergh J.W., Klinkhamer P.J., Et al., Is there a common etiology for the rising incidence of and decreasing survival with adenocarcinoma of the lung?, Epidemiology, 12, (2001)
21. Funai K., Yokose T., Ishii G., Et al., Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung, Am J Surg Pathol, 27, (2003)
22. Kalemkerian G.P., Akerley W., Bogner P., Et al., Small cell lung cancer, J Natl Compr Cancer Netw, 11, 1, pp. 78-98, (2013)
23. Detterbeck F.C., Boffa D.J., Kim A.W., Tanoue L.T., The eighth edition lung cancer stage classification, Chest, 151, 1, pp. 193-203, (2017)
24. Silvestri G.A., Gould M.K., Margolis M.L., Tanoue L.T., McCrory D., Toloza E., Et al., Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines, Chest, 132, 3, pp. 178S-201S, (2007)
25. Crino L., Weder W., Van Meerbeeck J., Felip E., Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 21, pp. v103-v105, (2010)
26. Yasufuku K., Chiyo M., Koh E., Moriya Y., Iyoda A., Sekine Y., Et al., Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer, Lung Cancer, 50, 3, pp. 347-354, (2005)
27. Hammoud Z.T., Anderson R.C., Meyers B.F., Guthrie T.J., Roper C.L., Cooper J.D., Et al., The current role of mediastinoscopy in the evaluation of thoracic disease, J Thorac Cardiovasc Surg, 118, 5, pp. 894-899, (1999)
28. Postmus P., Kerr K., Oudkerk M., Senan S., Waller D., Vansteenkiste J., Et al., Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 28, pp. iv1-iv21, (2017)
29. Albain K.S., Swann R.S., Rusch V.W., Turrisi A.T., Shepherd F.A., Smith C., Et al., Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer:A phase III randomised controlled trial, Lancet, 374, 9687, pp. 379-386, (2009)
30. Cortes A.A., Urquizu L.C., Cubero J.H., Adjuvant chemotherapy in non-small cell lung cancer:State-of-the-art, Transl Lung Cancer Res, 4, 2, (2015)
31. Ginsberg R.J., Rubinstein L.V., Group L.C.S., Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer, Ann Thorac Surg, 60, 3, pp. 615-623, (1995)
32. Qiu C., Wang G., Xu J., Cui L., Dong W., Ni Y., Et al., Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderly, Int J Surg, 37, pp. 1-7, (2017)
33. Kreinbrink P., Blumenfeld P., Tolekidis G., Sen N., Sher D., Marwaha G., Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥ 80 years old): Extremely safe and effective, J Geriatr Oncol, 8, 5, pp. 351-355, (2017)
34. Antonia S.J., Villegas A., Daniel D., Vicente D., Murakami S., Hui R., Et al., Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer, N Engl J Med, 377, 20, pp. 1919-1929, (2017)
35. Brahmer J.R., Rodriguez-Abreu D., Robinson A.G., Hui R., Csoszi T., Fulop A., Et al., Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): A multicentre, international, randomised, open-label phase 3 trial, Lancet Oncol, 18, 12, pp. 1600-1609, (2017)
36. Fruh M., De Ruysscher D., Popat S., Et al., Small-cell lung cancer (SCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 24, pp. vi99-vi105, (2013)
37. Vitale C., D'Amato M., Calabro P., Stanziola A.A., Mormile M., Molino A., Venous thromboembolism and lung cancer: A review, Multidiscip Respir Med, 10, 1, (2015)
38. Chew H.K., Davies A.M., Wun T., Harvey D., Zhou H., White R.H., Et al., The incidence of venous thromboembolism among patients with primary lung cancer, J Thromb Haemost, 6, 4, pp. 601-608, (2008)
39. White R.H., Chew H.K., Zhou H., Parikh-Patel A., Harris D., Harvey D., Wun T., Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528, 693 adults, Arch Intern Med, 165, pp. 1782-1787, (2005)
40. Sato T., Tsujino I., Ikeda D., Ieko M., Nishimura M., Trousseau’s syndrome associated with tissue factor produced by pulmonary adenocarcinoma, Thorax, 61, pp. 1009-1010, (2006)
41. Kadlec J., Skrickova Z.M., The incidence and predictors of thromboembolic events in patients with lung cancer, Sci World J, 125706, (2014)
42. Alexander M., Kirsa S., Wolfe R., Thromboembolism in lung cancer-an area of urgent unmet need, Lung Cancer, 84, 3, pp. 275-280, (2014)
43. Lyman G.H., Khorana A.A., Falanga A., Clarke-Pearson D., Flowers C., Jahanzeb M., Et al., American Society of Clinical Oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer, J Clin Oncol, 25, pp. 490-505, (2007)
44. Lioudaki S., Kontopodis N., Palioudakis S., Koutsopoulos A.V., Drositis I., Ioannou C.V., Acute aortic occlusion due to tumor embolism in a patient with lung malignancy, SAGE Open Med Case Rep, 5, (2017)
45. Xirometritis N., Klonaris C., Papas S., Et al., Recurrent peripheral arterial embolism from pulmonary cancer: Case report and review of the literature, Int Angiol, 19, pp. 79-83, (2000)
46. Alcantara V.Q.M., Souza G.G.C., Borges R.D.B., Et al., Acute arterial occlusion of lower limbs caused by tumor embolism in a patient with lung cancer, J Vasc Bras, 11, pp. 334-336, (2012)
47. Ascione L., Granata G., Accadia M., Et al., Ultrasonography in embolic stroke: The complementary role of transthoracic and transesophageal echocardiography in a case of systemic embolism by tumor invasion of the pulmonary veins in a patient with unknown malignancy involving the lung, Eur J Echocardiogr, 5, pp. 304-307, (2004)
48. Panagopoulos N., Leivaditis V., Koletsis E., Et al., Pancoast tumors: Characteristics and preoperative assessment, J Thorac Dis, 6, pp. S108-S115, (2014)
49. Detterbeck F.C., Pancoast (superior sulcus) tumors, Ann Thorac Surg, 63, pp. 1810-1818, (1997)
50. Pancoast H.K., Superior pulmonary sulcus tumor: Tumor characterized by pain, Horner’s syndrome, destruction of bone and atrophy of hand muscles, JAMA, 99, pp. 1391-1396, (1932)
51. Heelan R.T., Demas B.E., Caravelli J.F., Et al., Superior sulcus tumors: CT and MRI imaging, Radiology, 170, pp. 637-641, (1989)
52. Rusch V.W., Giroux D.J., Kraut M.J., Et al., Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: Long-term results of Southwest Oncology Group trial 9416 (Intergroup Trial 0160), J Clin Oncol, 25, 3, pp. 313-318, (2007)
53. Kunitoh H., Kato H., Tsuboi M., Et al., Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: Report of Japan Clinical Oncology Group trial 9806 [published correction appears in J Clin Oncol. 2011 Nov 20;29(33):4472. Ichonose, Yukito [corrected to Ichinose, Yukito]], J Clin Oncol, 26, 4, pp. 644-649, (2008)
54. Bandyopadhyay D., Panchabhai T.S., Bajaj N.S., Patil P.D., Bunte M.C., Primary pulmonary artery sarcoma: A close associate of pulmonary embolism-20-year observational analysis, J Thorac Dis, 8, 9, pp. 2592-2601, (2016)
55. Flaherty G., McCarthy P., Mortimer G., Pulmonary artery leiomyosarcoma: An unusual cause of shortness of breath, Ir J Med Sci, 180, pp. 275-278, (2011)
56. Singla Long S., Johnson P.T., Hruban R.H., Et al., CT features of pulmonary artery sarcoma: Critical aid to a challenging diagnosis, Emerg Radiol, 17, pp. 153-155, (2010)
57. Tueller C., Fischer Biner R., Minder S., Et al., FDG-PET in diagnostic work-up of pulmonary artery sarcomas, Eur Respir J, 35, pp. 444-446, (2010)
58. Lv Y., Wang F., Qian W., Sun G., Treatment of a recurrent pulmonary artery leiomyosarcoma with a combination of surgery, chemotherapy, and radiotherapy: A case report and literature review, Oncol Lett, 9, 4, pp. 1545-1548, (2015)
59. Blackmon S.H., Rice D.C., Correa A.M., Et al., Management of primary pulmonary artery sarcomas, Ann Thorac Surg, 87, pp. 977-984, (2009)
60. Duwe B.V., Sterman D.H., Musani A.I., Tumors of the mediastinum, Chest, 128, 4, pp. 2893-2909, (2005)
61. Engels E.A., Epidemiology of thymoma and associated malignancies, J Thorac Oncol, 5, pp. S260-S265, (2010)
62. Marx A., Chan J.K., Coindre J.M., Et al., The 2015 World Health Organization classification of tumors of the thymus: Continuity and changes, J Thorac Oncol, 10, 10, pp. 1383-1395, (2015)
63. Morgenthaler T.I., Brown L.R., Colby T.V., Harper C.M., Coles D.T., Thymoma, Mayo Clin Proc, 68, 11, pp. 1110-1123, (1993)
64. Okumura M., Shiono H., Minami M., Et al., Clinical and pathological aspects of thymic epithelial tumors, Gen Thorac Cardiovasc Surg, 56, 1, pp. 10-16, (2008)
65. Wolfe G.I., Kaminski H.J., Aban I.B., Et al., Randomized trial of Thymectomy in Myasthenia Gravis [published correction appears in N Engl J Med. 2017 May 25;376(21):2097. [Dosage error in article text]], N Engl J Med, 375, 6, pp. 511-522, (2016)
66. Bernard C., Frih H., Pasquet F., Et al., Thymoma associated with autoimmune diseases: 85 cases and literature review, Autoimmun Rev, 15, 1, pp. 82-92, (2016)
67. Juanpere S., Canete N., Ortuno P., Martinez S., Sanchez G., Bernado L., A diagnostic approach to the mediastinal masses, Insights Imaging, 4, 1, pp. 29-52, (2013)
68. Carter B.W., Benveniste M.F., Madan R., Et al., IASLC/ITMIG staging system and lymph node map for thymic epithelial neoplasms, Radiographics, 37, 3, pp. 758-776, (2017)
69. Detterbeck F.C., Nicholson A.G., Kondo K., Van Schil P., Moran C., The Masaoka-Koga stage classification for thymic malignancies: Clarification and definition of terms, J Thorac Oncol, 6, pp. S1710-S1716, (2011)
70. Masaoka A., Monden Y., Nakahara K., Et al., Follow-up study of thymomas with special reference to their clinical stages, Cancer, 48, pp. 2485-2492, (1981)
71. Detterbeck F.C., Asamura H., Crowley J., Et al., Staging and Prognostic Factors Committee
72. Members of the Advisory Boards
73. Participating Institutions of the Thymic Domain. The IASLC/ITMIG thymic malignancies staging project: Development of a stage classification for thymic malignancies, J Thorac Oncol, 8, pp. 1467-1473, (2013)
74. Huang J., Ahmad U., Antonicelli A., Et al., International Thymic Malignancy Interest Group International Database Committee and Contributors. Development of the international thymic malignancy interest group international database: An unprecedented resource for the study of a rare group of tumors, J Thorac Oncol, 9, pp. 1573-1578, (2014)
75. Detterbeck F.C., Stratton K., Giroux D., Et al., The IASLC/ITMIG thymic epithelial tumors staging project: Proposal for an evidence-based stage classification-system for the forthcoming (8th) edition of the TNM classification of malignant tumors, J Thorac Oncol, 9, pp. 65-72, (2014)
76. Girard N., Ruffini E., Marx A., Faivre-Finn C., Peters S., ESMO Guidelines Committee. Thymic epithelial tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 26, pp. v40-v55, (2015)
77. Novellis P., Veronesi G., Raffeeq Z., Alloisio M., Thymoma surgery: Extreme surgical indications, J Thorac Dis, 11, 7, pp. 2695-2699, (2019)
78. Bacha E.A., Chapelier A.R., Macchiarini P., Fadel E., Dartevelle P.G., Surgery for invasive primary mediastinal tumors, Ann Thorac Surg, 66, 1, pp. 234-239, (1998)
79. Fujino S., Tezuka N., Watarida S., Katsuyama K., Inoue S., Mori A., Reconstruction of the aortic arch in invasive thymoma under retrograde cerebral perfusion, Ann Thorac Surg, 66, 1, pp. 263-264, (1998)
80. Venuta F., Rendina E.A., Anile M., de Giacomo T., Vitolo D., Coloni G.F., Thymoma and thymic carcinoma, Gen Thorac Cardiovasc Surg, 60, 1, pp. 1-12, (2012)
81. Takeda S.-I., Miyoshi S., Ohta M., Minami M., Masaoka A., Matsuda H., Primary germ cell tumors in the mediastinum, Cancer, 97, pp. 367-376, (2003)
82. Liu Y., Wang Z., Peng Z.M., Yu Y., Management of the primary malignant mediastinal germ cell tumors: Experience with 54 patients, Diagn Pathol, 9, (2014)
83. Mishra S., Das Majumdar S.K., Sable M., Parida D.K., Primary malignant mediastinal germ cell tumors: A single institutional experience, South Asian J Cancer, 9, 1, pp. 27-29, (2020)
84. No T.H., Seol S.H., Seo G.W., Et al., Benign Mature Teratoma in Anterior Mediastinum, J Clin Med Res, 7, 9, pp. 726-728, (2015)
85. Fujimoto Y., Monden Y., Nakahara K., Kawashima Y., Benign mediastinal teratoma associated Klinefelter’s syndrome, Jpn J Surg, 15, pp. 221-224, (1985)
86. Mori K., Eguchi K., Moriyama H., Miyazawa N., Kodama T., Computed tomography of anterior mediastinal tumors. Differentiation between thymoma and germ cell tumor, Acta Radiol, 28, pp. 395-401, (1987)
87. Asamura H., Tsuchiya R., Goya T., Et al., Malignant germ cell tumor of the mediastinum: A multimodality therapeutic approach, Surg Today, 24, pp. 137-141, (1994)
88. Walsh G.L., Taylor G.D., Nesbitt J.C., Amato R.J., Intensive chemotherapy and radical resections for primary non-seminomatous mediastinal germ cell tumors, Ann Thorac Surg, 69, pp. 337-344, (2000)
89. Heit J.A., O'Fallon W.M., Petterson T.M., Et al., Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: A population-based study, Arch Intern Med, 162, (2002)
90. Bauer K.A., Venous thromboembolism in malignancy, J Clin Oncol, 18, (2000)
91. Sorensen H.T., Mellemkjaer L., Olsen J.H., Baron J.A., Prognosis of cancers associated with venous thromboembolism, N Engl J Med, 343, (2000)
92. Lee A.Y.Y., When can we stop anticoagulation in patients with cancer-associated thrombosis?, Blood, 130, 23, pp. 2484-2490, (2017)
93. Rice T.W., Rodriguez R.M., Light R.W., The superior vena cava syndrome: Clinical characteristics and evolving etiology, Medicine, 85, (2006)
94. Yellin A., Rosen A., Reichert N., Lieberman Y., Superior vena cava syndrome. The myth--the facts, Am Rev Respir Dis, 141, (1990)
95. Markman M., Diagnosis and management of superior vena cava syndrome, Cleve Clin J Med, 66, (1999)
96. Armstrong B.A., Perez C.A., Simpson J.R., Hederman M.A., Role of irradiation in the management of superior vena cava syndrome, Int J Radiat Oncol Biol Phys, 13, (1987)
97. Rowell N.P., Gleeson F.V., Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: A systematic review, Clin Oncol (R Coll Radiol), 14, (2002)
98. Wurschmidt F., Bunemann H., Heilmann H.P., Small cell lung cancer with and without superior vena cava syndrome: A multivariate analysis of prognostic factors in 408 cases, Int J Radiat Oncol Biol Phys, 33, (1995)
99. Airan B., Sharma R., Iyer K.S., Et al., Malignant thymoma presenting as intracardiac tumor and superior vena caval obstruction, Ann Thorac Surg, 50, (1990)
100. Dib H.R., Friedman B., Khouli H.I., Et al., Malignant thymoma. A complicated triad of SVC syndrome, cardiac tamponade, and DIC, Chest, 105, (1994)
101. Holbert B.L., Libshitz H.I., Superior vena caval syndrome in primary mediastinal germ cell tumors, Can Assoc Radiol J, 37, (1986)
102. Chen J.C., Bongard F., Klein S.R., A contemporary perspective on superior vena cava syndrome, Am J Surg, 160, (1990)
103. Greillier L., Barlesi F., Doddoli C., Et al., Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: A future ‘standard’ procedure?, Respiration, 71, (2004)
104. Nagata T., Makutani S., Uchida H., Et al., Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava, Cardiovasc Intervent Radiol, 30, (2007)
105. Morin S., Grateau A., Reuter D., Et al., Management of superior vena cava syndrome in critically ill cancer patients, Support Care Cancer, 26, (2018)
106. Kee S.T., Kinoshita L., Razavi M.K., Et al., Superior vena cava syndrome: Treatment with catheter-directed thrombolysis and endovascular stent placement, Radiology, 206, (1998)
107. Tanigawa N., Sawada S., Mishima K., Et al., Clinical outcome of stenting in superior vena cava syndrome associated with malignant tumors. Comparison with conventional treatment, Acta Radiol, 39, (1998)
108. Urruticoechea A., Mesia R., Dominguez J., Et al., Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer, Lung Cancer, 43, (2004)
109. Baltayiannis N., Magoulas D., Anagnostopoulos D., Et al., Percutaneous stent placement in malignant cases of superior vena cava syndrome, J BUON, 10, (2005)
110. Courtheoux P., Alkofer B., Al Refai M., Et al., Stent placement in superior vena cava syndrome, Ann Thorac Surg, 75, (2003)
111. Uberoi R., Quality assurance guidelines for superior vena cava stenting in malignant disease, Cardiovasc Intervent Radiol, 29, (2006)
112. Fagedet D., Thony F., Timsit J.F., Et al., Endovascular treatment of malignant superior vena cava syndrome: Results and predictive factors of clinical efficacy, Cardiovasc Intervent Radiol, 36, (2013)
113. Sobrinho G., Aguiar P., Stent placement for the treatment of malignant superior vena cava syndrome -a single-center series of 56 patients, Arch Bronconeumol, 50, (2014)
114. Bialkowski J., Szkutnik M., Fiszer R., Et al., Percutaneous dilatation of coarctation of the aorta, stenotic pulmonary arteries or homografts, and stenotic superior vena cava using Andrastents XL and XXL, Kardiol Pol, 69, (2011)
115. Gwon D.I., Ko G.Y., Kim J.H., Et al., Malignant superior vena cava syndrome: A comparative cohort study of treatment with covered stents versus uncovered stents, Radiology, 266, (2013)
116. Nguyen N.P., Borok T.L., Welsh J., Vinh-Hung V., Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome, Thorax, 64, (2009)
117. Lanciego C., Pangua C., Chacon J.I., Et al., Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome, AJR Am J Roentgenol, 193, (2009)
118. Quaretti P., Galli F., Moramarco L.P., Et al., Stent grafts provided superior primary patency for central venous stenosis treatment in comparison with angioplasty and bare metal stent:A retrospective Single Center Study on 70 hemodialysis patients, Vasc Endovasc Surg, 50, (2016)
119. Wilson L.D., Detterbeck F.C., Yahalom J., Clinical practice. Superior vena cava syndrome with malignant causes, N Engl J Med, 356, (2007)
120. Kvale P.A., Selecky P.A., Prakash U.B., American College of Chest Physicians. Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition), Chest, 132, (2007)
121. Bacha E.A., Chapelier A.R., Macchiarini P., Et al., Surgery for invasive primary mediastinal tumors, Ann Thorac Surg, 66, (1998)
122. Chen K.N., Xu S.F., Gu Z.D., Et al., Surgical treatment of complex malignant anterior mediastinal tumors invading the superior vena cava, World J Surg, 30, (2006)
123. Shimizu N., Moriyama S., Aoe M., Et al., The surgical treatment of invasive thymoma. Resection with vascular reconstruction, J Thorac Cardiovasc Surg, 103, (1992)
124. Magnan P.E., Thomas P., Giudicelli R., Et al., Surgical reconstruction of the superior vena cava, Cardiovasc Surg, 2, (1994)
125. Nakano T., Endo S., Kanai Y., Et al., Surgical outcomes after superior vena cava reconstruction with expanded polytetrafluoroethylene grafts, Ann Thorac Cardiovasc Surg, 20, (2014)
126. Yu J.B., Wilson L.D., Detterbeck F.C., Superior vena cava syndrome-a proposed classification system and algorithm for management, J Thorac Oncol, 3, (2008)